AI and Cryo-EM: A Powerful Alliance for Unraveling Biological Mysteries
As we delve deeper into the uncharted territories of biotechnology, the convergence of artificial intelligence (AI) and cryo-electron microscopy (Cryo-EM) …
All Posts
Beyond Traditional Medicine: Exploring the Revolutionary Therapies Transforming Patient Care
Biotechnology has revolutionized the healthcare industry, and with the increasing demand for advanced therapies, the focus has shifted towards innovative …
Breaking Through the Investment Gap: Mark Andrews Discusses British Patient Capital's Life Sciences Fund
In this interview, we speak with Mark Andrews, Investment Director, Life Sciences, Funds at British Patient Capital, the largest domestic …
Insilico Medicine’s Generative AI Patent Provides Advantage in AI Drug Discovery Race
Companies are increasingly turning to generative artificial intelligence (AI) to develop new therapeutics, giving biotech companies with patents on these …
Decentralized Clinical Trials Software’s in 2023: What to Expect
Healthcare technology is advancing at an unprecedented pace, and the clinical trials industry is no exception. The past few years …
Biopharma Financial Climate and Market Dynamics in 2023: Interview with David Dowling, Ropes & Gray
Recently, David Dowling, a senior lawyer at Ropes & Gray, has outlined his predictions for M&A in the European biotech …
The Time for Breakthroughs in Antibiotic Discovery
Since a revolutionary discovery of penicillin in 1928 by Scottish bacteriologist and Nobel laureate Alexander Fleming, numerous inventions of new …
British Patient Capital Backs Notable Cancer Research with $7 million Investment in Grey Wolf Therapeutics
British Patient Capital, a subsidiary of the British Business Bank, invested $7 million in Grey Wolf Therapeutics, an Oxford-based biotech …
Unlocking the Proteome's Secrets: The Advancement of Single-Molecule Protein Sequencing Techniques
Even though characterizing the proteome, the complete set of proteins made by a cell or organism, can yield important insights …
17 Companies Building the Future of Drug Development on a Chip
In the early 2000s, the concept of organ-on-a-chip technology, also known as microphysiological systems, emerged as a way to replicate …
Democratizing Early Drug Discovery through Artificial Intelligence: Interview with Syntekabio CEO Jongsun Jung
Before the age of modern drug discovery, the pharmaceutical industry had been plagued with uncertainty and processing challenges, including the …
2022 in Retrospect: 10 Breakthrough Technologies in Drug Discovery
Reflecting on 2022, let’s review several breakthrough technologies that are shaping the future of biology research and drug discovery. I …
